Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy
Abstract Background Interleukin‐1 alpha (IL‐1α) is a pro‐inflammatory cytokine that can activate immune effector cells and trigger anti‐tumor immune responses. However, dose‐limiting toxicities including cytokine storm and hypotension has limited its use in the clinic as a cancer therapy. We propose...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wiley
2023-05-01
|
| Serie: | Bioengineering & Translational Medicine |
| Ämnen: | |
| Länkar: | https://doi.org/10.1002/btm2.10465 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|